Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for subject:(filamentous phage). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Alberta

1. Bailey, Justin, J. Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier.

Degree: PhD, Department of Chemistry, 2013, University of Alberta

Glycans are a diverse and integral component of all biological organisms, making them an ideal target for vaccine development. Carbohydrates often act as weak antigens, lacking the T cell epitopes required to recruit T cell help which is vital to develop a strong and long lasting protective antibody response. Chemical conjugation of glycan antigens to a protein carrier to elicit T cell help has been a successful strategy to improve the strength of the immune response towards glycan-derived haptens. The hapten-carrier concept has been successfully used for numerous synthetic glycoconjugate vaccines now approved for human use. HIV-1 appears to be an ideal candidate for developing a glycoconjugate vaccine as the exposed HIV-1 envelope protein, gp120, is one of the most heavily N-glycosylated proteins known. Glycoconjugate vaccines displaying the glycans of gp120 have thus far failed to elicit protective antibodies that bind to gp120 or neutralize viruses bearing HIV 1 Env. The lack of cross reactivity has been attributed to an inability of the glycoconjugate vaccines to faithfully mimic the carbohydrate-dense gp120 surface. Described herein is the synthesis of two mannosyl thiol analogues of gp120 glycans, their chemical conjugation to a filamentous phage carrier, and the LC-UV-MS methodology developed to characterize the resulting glycoconjugates. The mannosyl thiols provide access to highly reactive linker chemistry while maintaining a minimal linker length, which may be essential to mimic the limited flexibility of the tightly packed glycans of gp120. Filamentous phage possess a structurally homogenous, repeating surface with closely spaced, solvent exposed amines available for conjugation. This arrangement is ideal for mimicking the glycan shield of gp120. Coupling of mannosyl thiol analogues to the phage carrier produced a densely glycosylated surface where over 80% of the 8,100+ conjugation sites of the phage were occupied, as was determined to an unprecedented level of clarity by LC-UV-MS. The phage glycoconjugates were shown to interact with anti-HIV-1 glycan-specific antibody 2G12 with 0.5 nM affinity, ranking it as one of the best 2G12-binding antigenic mimics described thus far. Mice immunized with the phage glycoconjugates elicited high titres of carbohydrate-specific antibodies that were unable to cross react with gp120.

Subjects/Keywords: filamentous phage; HIV-1; glycoconjugate vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bailey, Justin, J. (2013). Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier. (Doctoral Dissertation). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/1z40kt229

Chicago Manual of Style (16th Edition):

Bailey, Justin, J. “Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier.” 2013. Doctoral Dissertation, University of Alberta. Accessed June 16, 2019. https://era.library.ualberta.ca/files/1z40kt229.

MLA Handbook (7th Edition):

Bailey, Justin, J. “Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier.” 2013. Web. 16 Jun 2019.

Vancouver:

Bailey, Justin J. Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier. [Internet] [Doctoral dissertation]. University of Alberta; 2013. [cited 2019 Jun 16]. Available from: https://era.library.ualberta.ca/files/1z40kt229.

Council of Science Editors:

Bailey, Justin J. Rational Design of an HIV-1 Vaccine using a Filamentous Phage Carrier. [Doctoral Dissertation]. University of Alberta; 2013. Available from: https://era.library.ualberta.ca/files/1z40kt229

.